Month: January 2023

To Nasdaq Copenhagen 5 januar 2023 FIXING OF COUPON RATES – 2 NEW By mistake, the 2 bonds mentioned below were not included in the announcement from 23 December 2022, when Nykredit Realkredit published a number of new coupon rates on variable rate bonds effective from 1 January 2023. Fixing of coupon rates effective from 1 January 2023 Effective from 1 January 2023, the coupon rates of floating-rate on 2 more bonds issued by Nykredit Realkredit A/S will be adjusted. Bonds with quarterly interest rate fixingThe new coupon rates will apply from 1 January 2023 to 31 March 2023: Uncapped bondsDK0009541369, (32H), maturity in 2025, new rate as at 1 January 2023: 2.5550% paDK0009541526, (32G), maturity in 2025, new rate as at 1 January 2023: 2.6564% pa Questions may be directed to Investor Relations at investor_relations@nykredit.dk or...

LA JOLLA, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) — Private Bancorp of America, Inc. (OTCQX: PBAM) (“Company”) and CalPrivate Bank (“Bank”) President & CEO Rick Sowers announced today that a new finance and accounting leadership team has joined the Company and the Bank. The team will be led by Cory D. Stewart, who was appointed Executive Vice President and Chief Financial Officer of both the Company and Bank effective January 4, 2023. Joining Cory will be Tony Dal Maso, SVP Accounting & Financial Reporting, Mark Hettel, SVP Finance Strategy & Transformation and Erik Torseth, SVP Finance & Treasury. Cory succeeds Mag Wangsuwana who will remain with the company during the first quarter to ensure a smooth transition. “We are very excited to have such a seasoned and experienced finance and accounting team join the...

Foresight Solar & Technology VCT plcLEI: 21380013CXOR8N6OD977 Sale of Ordinary Shares portfolio Foresight Solar & Technology VCT plc (“the Fund”) is pleased to announce the exchange of contracts for the sale of its portfolio of solar assets held in the Ordinary Share class (the “sale”), totalling 70MWp1. Subject to the satisfaction of certain conditions, this sale is anticipated to complete over the next two months. The final sale price will deliver a strong return to shareholders in the Fund of approximately 140p per Ordinary share compared to the last reported Net Asset Value of 131.2p per share as at 30 September 2022 and reflects Foresight’s capabilities in asset management optimisation. The total return to investors will be approximately 185p. Ernie Richardson, Chair of Foresight Solar & Technology VCT plc, commented:...

New digital bank backed by Chunghwa Telecom launches on Temenos core banking platform to bring products to market fast and scale efficiently GENEVA, Jan. 05, 2023 (GLOBE NEWSWIRE) — Temenos (SIX: TEMN) today announced that Next Commercial Bank (Next Bank), a new digital bank backed by Chunghwa Telecom, Taiwan’s largest telecom operator, has gone live on Temenos core banking platform, opening to customers during 2022. One of the first digital banks in Taiwan to receive a virtual banking license from the island’s Financial Supervisory Commission (FSC), Next Bank is building a bank that makes financial management simple with innovative thinking, design aesthetics and friendly experiences. On Temenos open platform, Next Bank can bring products to market fast and scale efficiently. Today, the digital bank offers deposits, cards, loans...

TMP-301 (formerly HTL0014242) is a potent, selective, and orally available mGluR5 negative allosteric modulator (NAM) candidate discovered by Sosei Heptares and out-licensed to Tempero Bio Phase 1 study in healthy volunteers expected to begin in Q1 2023 with support from a US$5.3M grant from the US National Institute on Drug Abuse (NIDA) Tempero Bio was created by Aditum Bio in collaboration with Sosei Heptares in 2020 to advance the clinical development of mGluR5 NAM candidates to develop therapies targeting substance use disorders and anxiety Sosei Heptares holds a strategic equity stake in Tempero Bio and retains an economic interest in TMP-301 and other compounds in the mGluR5 NAM program out-licensed to Tempero BioTOKYO and CAMBRIDGE, United Kingdom, Jan. 05, 2023 (GLOBE NEWSWIRE) — Sosei Group Corporation (“the Company”;...

OSLO, Norway (5 January 2023) – TGS ASA will host its Capital Markets Day in Oslo, Norway, on 7 March 2023. In addition to presentations of the business outlook and strategy by the TGS management, Dr. Scott Tinker, Director of the Bureau of Economic Geology at the University of Texas at Austin and CEO of Tinker Energy Associates, LLC., will present his perspectives on the long-term energy outlook. The presentations will last from CET 13.00 to approximately CET 16.00 and will be streamed live at tgs.com. In addition, presentation materials will be published at approximately CET 7.00 on the same day. The event will take place at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway and afterward, we invite attendees to join us for a reception. Please register for TGS Capital Markets Day by emailing investor@tgs.com.  About TGSTGS provides...

FDA accepts nirsevimab application as first protective option against RSV disease for all infantsNirsevimab would be the first broadly protective option against RSV disease designed for all infants, if approved Nirsevimab delivered consistent protection of approximately 80% against medically attended RSV disease across several trials in healthy term and preterm infants and has been approved under accelerated review in the EU and the UKParis, January 5, 2023. The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has accepted the Biologics License Application (BLA) for nirsevimab for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants entering or during their first RSV season and for children up to 24 months of age who remain vulnerable to severe...

AKROPOLIS Vilnius extension 1 AKROPOLIS Vilnius extensionAKROPOLIS Vilnius extension 2 AKROPOLIS Vilnius extensionDuring a design publicity meeting held remotely, design proposals for a new building planned to be constructed by the shopping and entertainment centre Akropolis in the capital city of Lithuania and its architectural solutions have been presented to the public. A one-storey building of 480 m2 is going to be constructed near the shopping and entertainment centre Akropolis in Vilnius, which will emerge replacing temporary structures that are currently there. The new building is going to be built between entrances No. 4 and No. 6 of the shopping centre, expanding the retail area. There will be 11 parking spaces by the planned new commercial building, 2 of them will have charging stations for electric cars and 1 will be a...

GENOMICS | GENETICS | R&D | DIAGNOSIS TESTS                  Genomic Vision announces successful beta testing of FiberSmart®FiberSmart® is Genomic Vision’s Artificial Intelligence (AI) powered and fully integrated software automating genomic analysis FiberSmart® leverages cutting-edge AI to rapidly analyze DNA replication kinetics and provide a seamless user experience FiberSmart platform was successfully tested by AstraZeneca and the Fritz Lipmann InstituteBagneux (France), 5 January 2023 – Genomic Vision (FR0011799907 – GV, – the “Company”), a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, today announced that its new integrated software FiberSmart® has been successfully tested and validated by AstraZeneca (LSE/STO/Nasdaq: AZN), and...